EASL – International Liver Congress 2021

Published on 12/02/2021

23–26 June 2021
Digital congress

ENYO Pharma will be present from the 23th to the 26th of June 2021 at the digital EASL International Liver Congress with a first poster “A phase 2 study testing FXR agonist Vonafexor in treatment naive patients with chronic hepatitis B (CHB): preliminary week 16 results” (EASL-ICL 2021 Abstract No. 2844) in the Hepatitis B/D Therapy Session:

And a second poster “Farnesoid X receptor alpha ligands inhibit in vitro HDV replication and virion secretion and infectivity”

Read next in 'Events'

• FEDERG meeting - 10 years, 2024
• The 2024 international workshop on Alport syndrome
• Alport Connect 2024, la rencontre annuelle américaine avec les patients atteints du syndrome d’Alport
• ASN Kidney Week 2024
• ASN Kidney Week 2024